Larvol Delta - Rexahn-Announces-Target-Enrollment-Reached-in-Phase-2a-Clinical-Trial-of-RX3117-in-Combination-With-ABRAXANE-in-Firstline-Metastatic-Pancreatic-Cancer-Patients

Abraxane (albumin-bound paclitaxel) - Celgene, Otsuka

fluorocyclopentenylcytosine (RX-3117) - Rexahn

http://globenewswire.com/news-release/2019/03/04/1745943/0/en/Rexahn-Announces-Target-Enrollment-Reached-in-Phase-2a-Clinical-Trial-of-RX-3117-in-Combination-With-ABRAXANE-in-First-line-Metastatic-Pancreatic-Cancer-Patients.html

Mar 8, 2019

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next